Current stroke guidelines 1-3 recommend intravenous thrombolysis (IVT) using the recombinant tissue plasminogen activator (r-tPA) at a standard-dose (0.9mg/kg, alteplase) for patients with acute ischemic stroke (AIS). This evidence concerns the gene PLAT and androgen insensitivity syndrome.